Literature DB >> 7551292

Human papillomavirus infection in the malignant and premalignant head and neck epithelium.

P Fouret1, F Martin, A Flahault, J L Saint-Guily.   

Abstract

A prospective study was undertaken to determine the prevalence and histological correlates of human papillomavirus infection in the head and neck epithelium. Oral, pharyngeal, and laryngeal paraffin-embedded samples were analyzed by polymerase chain reaction with use of human papillomavirus E6 consensus sequence primers. Human papillomavirus infection was detected in 20 of 126 (15.9%) patients. Twenty-five of 230 (10.9%) samples contained human papillomavirus DNA. Papillomaviruses were detected in 15 of 131 (11.4%) head and neck squamous cell carcinomas, in 3 of 32 (9.4%) dysplasias, and 2 of 19 (10.5%) keratoses. The most commonly identified human papillomavirus in cancerous, precancerous, and keratotic lesions was type 16 (80.0% of the isolates). Five papillomas were shown to contain human papillomavirus type 6. No other lesion in 42 samples contained human papillomavirus. Our data are consistent with the hypothesis that infection with certain types of human papillomavirus contributes to head and neck cancer although this may be so only in a minority of cases. Human papillomavirus infection may play a role in the earliest stages of tumorigenesis, since papillomaviruses can be found in laryngeal premalignant and keratotic lesions, which are closely linked to tobacco use.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551292     DOI: 10.1097/00019606-199506000-00008

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  9 in total

Review 1.  Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

Authors:  Vijayvel Jayaprakash; Mary Reid; Elizabeth Hatton; Mihai Merzianu; Nestor Rigual; James Marshall; Steve Gill; Jennifer Frustino; Gregory Wilding; Thom Loree; Saurin Popat; Maureen Sullivan
Journal:  Oral Oncol       Date:  2011-08-03       Impact factor: 5.337

Review 2.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

Review 3.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

4.  Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia.

Authors:  Rajan Saini; Thean-Hock Tang; Rosnah Binti Zain; Sok Ching Cheong; Kamarul Imran Musa; Deepti Saini; Abdul Rashid Ismail; Mannil Thomas Abraham; Wan Mahadzir Wan Mustafa; Jacinta Santhanam
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-24       Impact factor: 4.553

5.  New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Authors:  Kevin David Shield; Claire Marant Micallef; Catherine de Martel; Isabelle Heard; Francis Megraud; Martyn Plummer; Jérôme Vignat; Freddie Bray; Isabelle Soerjomataram
Journal:  Eur J Epidemiol       Date:  2017-12-06       Impact factor: 8.082

Review 6.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

Review 7.  The role of genetic factors in predisposition to squamous cell cancer of the head and neck.

Authors:  S Jefferies; R Eeles; D Goldgar; R A'Hern; J M Henk; M Gore
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 8.  Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Shanthy Sundaram; Ravi Mehrotra
Journal:  Head Neck Oncol       Date:  2009-06-25

9.  Human papillomavirus prevalence in invasive laryngeal cancer in the United States.

Authors:  Brenda Y Hernandez; Marc T Goodman; Charles F Lynch; Wendy Cozen; Elizabeth R Unger; Martin Steinau; Trevor Thompson; Maria Sibug Saber; Sean F Altekruse; Christopher Lyu; Mona Saraiya
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.